Terms: = Liver cancer AND HOXC13, HOX3G, 3229, ENSG00000123364, P31276, HOX3 AND Prognosis
3 results:
1. EPHB2 Activates β-Catenin to Enhance cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
Leung HW; Leung CON; Lau EY; Chung KPS; Mok EH; Lei MML; Leung RWH; Tong M; Keng VW; Ma C; Zhao Q; Ng IOL; Ma S; Lee TK
Cancer Res; 2021 Jun; 81(12):3229-3240. PubMed ID: 33903122
[TBL] [Abstract] [Full Text] [Related]
2. Overexpression of long noncoding RNA hoxc13-AS and its prognostic significance in hepatocellular carcinoma.
Zhou JF; Shi YT; Wang HG; Yang XZ; Wu SN
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7369-7374. PubMed ID: 31539123
[TBL] [Abstract] [Full Text] [Related]
3. Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma.
Angenard G; Merdrignac A; Louis C; Edeline J; Coulouarn C
Dig Liver Dis; 2019 Sep; 51(9):1337-1343. PubMed ID: 31040073
[TBL] [Abstract] [Full Text] [Related]
